Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Akums Drugs & Pharmaceuticals Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company maintains a buffer capacity to accommodate demand spikes, with overall capacity utilization currently at about 47%, peaking at 55-60%. Key concall…
11 Aug 2026
Happy Forgings Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Visibility of new and incremental peak annual business of approximately INR 800 crores starting FY '27, scaling over 2-3 years (Page 5). Key concall takeaways…
11 Aug 2026
India Shelter Finance Corporation Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Profit after tax showed 33% YoY growth in Q3, with return on equity at 17.1%, signaling strong profitability trends. Key concall takeaways from India Shelter…
11 Aug 2026
Tata Technologies Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
. Key concall takeaways from Tata Technologies Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
11 Aug 2026
Honasa Consumer Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Company delivered highest-ever quarterly revenue with 21.7% growth, supported by 30% volume growth (UVG). Key concall takeaways from Honasa Consumer Ltd's Q3…
11 Aug 2026
Jindal Stainless Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Export Volumes: Export volumes have fallen by 26% year-on-year, but the company plans to maintain good export volumes despite global challenges. Key concall…
11 Aug 2026
ASK Automotive Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Growth is supported by GST 2.0 reforms reducing GST on products from 28% to 18%, boosting aftermarket demand and market share. Key concall takeaways from ASK…
11 Aug 2026
ROX Hi-Tech Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
250 crore in revenue in the next 18 to 24 months, which is aligned with plans to move from SME to main board listing. Key concall takeaways from ROX Hi-Tech…
11 Aug 2026
Ipca Laboratories Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company maintains healthy cash flows and had around INR 250 crores cash in the bank post land sale proceeds and other payments. Key concall takeaways from…
11 Aug 2026
ISGEC Heavy Engineering Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Private sector order book now comprises 85%, implying shorter cycles and better payment terms, supporting steady revenue growth (Page 12). Key concall…
11 Aug 2026
Max Estates Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Operating margins for Q3 FY '26, adjusting for marketing costs, were above 25%. Key concall takeaways from Max Estates Ltd's Q3 FY26 earnings call — and how it…
11 Aug 2026
R R Kabel Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company has planned a capex of around INR 1,200 crores over three years, with approximately 80% allocated to the cable segment. Key concall takeaways from…
11 Aug 2026
NIIT Learning Systems Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Organic growth stood at 14% year-on-year and 1.1% quarter-on-quarter in constant currency for the recent quarter. Key concall takeaways from NIIT Learning…
11 Aug 2026
J B Chemicals & Pharmaceuticals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Net cash position for JB Chemicals as of FY26 is around INR 1,200 crore. Key concall takeaways from J B Chemicals & Pharmaceuticals Ltd's Q4 FY26 earnings call…
11 Aug 2026
J B Chemicals & Pharmaceuticals Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
This strong order book supports confidence in maintaining margins around 28% for Q4. Key concall takeaways from J B Chemicals & Pharmaceuticals Ltd's Q3 FY26…
11 Aug 2026
Samhi Hotels Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Incremental INR 150 crores investment pending from GIC over the next 2 to 2.5 years, adding to free cash flow to support growth and orders (Page 18). Key…
11 Aug 2026
Digikore Studios Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Strong order book (~INR20 crores) and a robust bidding pipeline (~INR35 crores) with potential to convert INR8-10 crores soon. Key concall takeaways from…
11 Aug 2026
JSW Infrastructure Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
For FY '26, a capex spend of INR 3,500 crores is planned, split as INR 2,000 crores for ports and INR 1,500 crores for logistics. Key concall takeaways from…
11 Aug 2026
Cyient Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company highlights a strong net cash position (INR 1,434 crores at the end of Q3), indicating healthy liquidity. Key concall takeaways from Cyient Ltd's Q3…
11 Aug 2026
Intense Tech. Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
The increasing international business contribution (currently 30%) is seen as a critical growth driver. Key concall takeaways from Intense Tech.'s Q1 FY26…
11 Aug 2026